BCP-NC2-C12
Product Specifications
Target
Liposome
Related Pathways
Metabolism
Bioactivity
BCP-NC2-C12 is an ionizable cationic lipid employed in the formation of lipid nanoparticles (LNPs) for in vivo mRNA delivery. BCP-NC2-C12 LNPs, utilizing the CRISPR/Cas9 gene knockout method, achieve approximately a 90% reduction in serum PCSK9 protein levels.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
46568124 3x 1.0µg DNA
TFDP2 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 
17778066 1.0 µg DNA
DDIT3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
RC214172L4V 200 µL
SEMA6D (NM_024966) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details VWB96296-01 250 mg
N-[4- (1-Aminoethyl) phenyl]cyclopropanecarboxamide hydrochloride
Sign In for Pricing
View Details VWB96296-02 2.5 g
N-[4- (1-Aminoethyl) phenyl]cyclopropanecarboxamide hydrochloride
Sign In for Pricing
View Details